TIVDAK® (Tisotumab Vedotin) Approved By European Commission For Previously Treated Recurrent Or Metastatic Cervical Cancer
TIVDAK is approved for the treatment of recurrent or metastatic cervical cancer in the European Union, United States and Japan ...